Increased cyclooxygenase-2 expression associated with inflammatory cellular infiltration in elderly patients with vulvar cancer

Annals of the New York Academy of Sciences

Volumn 1095, Issue , 2007, Pages 143-153

  Taek, Sang Lee ^a,b   Yong, Tark Jeon ^b   Jae, Weon Kim ^b   Jae, Kyung Won ^b   Noh, Hyun Park ^b   In, Ae Park ^b   Yong, Sung Juhnn ^b   Soon, Beom Kang ^b   Hyo, Pyo Lee ^b   Yong, Sang Song ^b  

^a Seoul National University Boramae Hospital   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

COX 2; EGFR; Elderly patient; Immunohistochemistry; Inflammation; Vulvar cancer

Indexed keywords

CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR; AUTACOID;

ADULT; AGED; CANCER GRADING; CANCER STAGING; CELL DIFFERENTIATION; CELL INFILTRATION; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LYMPH NODE METASTASIS; MORBIDITY; PROTEIN EXPRESSION; VULVA CARCINOMA; AGE; ARTICLE; BIOSYNTHESIS; CELL MOTION; COMPARATIVE STUDY; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; SQUAMOUS CELL CARCINOMA; UPREGULATION; VULVA TUMOR;

ADULT; AGE FACTORS; AGED; CARCINOMA, SQUAMOUS CELL; CELL MOVEMENT; CYCLOOXYGENASE 2; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MIDDLE AGED; UP-REGULATION; VULVAR NEOPLASMS;

EID: 34247842804     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1397.018     Document Type: Conference Paper

References (34)

1. CRUM, C.P. 1992. Carcinoma of the vulva: epidemiology and pathogenesis. Obstet. Gynecol. 79: 448-454.
2. ZARCONE, R. et al. 1997. Current etiopathogenetic views in vulvar cancer. Panminerva Med. 39: 30-34.
3. CREASMAN, W.T., J.L. PHILLIPS & H.R. MENCK. 1997. The National Cancer Data Base report on early stage invasive vulvar carcinoma. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 80: 505-513.
4. JONES, R.W., J. BARANYAI & S. STABLES. 1997. Trends in squamous cell carcinoma of the vulva: the influence of vulvar intraepithelial neoplasia. Obstet. Gynecol. 90: 448-452.
5. LANDIS, S.H. et al. 1998. Cancer statistics, 1998. CA Cancer J. Clin. 48: 6-29.
6. WILLIAMS, C.S. & R.N. DUBOIS. 1996. Prostaglandin endoperoxide synthase: why two isoforms? Am. J. Physiol. 270: G393-G400.
7. FERRANDINA, G. et al. 2002. Cyclooxygenase-2 expression in endometrial carcinoma: correlation with clinicopathologic parameters and clinical outcome. Cancer 95: 801-807.
8. FERRANDINA, G. et al. 2002. Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patients. Ann. Oncol. 13: 1205-1211.
9. FERRANDINA, G. et al. 2002. Increased cyclooxygenase-2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patients. J. Clin. Oncol. 20: 973-981.
10. SALOMON, D.S. et al. 1995. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit. Rev. Oncol. Hematol. 19: 183-232.
11. SESHADRI, R. et al. 1996. Prospective study of the prognostic significance of epidermal growth factor receptor in primary breast cancer. Int. J. Cancer 69: 23-27.
12. MELLON, K. et al. 1995. Long-term outcome related to epidermal growth factor receptor status in bladder cancer. J. Urol. 153: 919-925.
13. DASSONVILLE, O. et al. 1993. Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer. J. Clin. Oncol. 11: 1873-1878.
14. HAMILTON, L.M. et al. 2003. The role of the epidermal growth factor receptor in sustaining neutrophil inflammation in severe asthma. Clin. Exp. Allergy 33: 233-240.
15. COFFEY, R.J. et al. 1997. Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells. Proc. Natl. Acad. Sci. USA 94: 657-662.
16. VADLAMUDI, R. et al. 1999. Regulation of cyclooxygenase-2 pathway by HER2 receptor. Oncogene 18: 305-314.
17. KINOSHITA, T. et al. 1999. Growth stimulation and induction of epidermal growth factor receptor by overexpression of cyclooxygenases 1 and 2 in human colon carcinoma cells. Biochim. Biophys. Acta 1438: 120-130.
18. IRANI, J. et al. 1997. Inflammation in benign prostatic hyperplasia: correlation with prostate specific antigen value. J. Urol. 157: 1301-1303.
19. WANG, W., A. BERGH & J.E. DAMBER. 2005. Cyclooxygenase-2 expression correlates with local chronic inflammation and tumor neovascularization in human prostate cancer. Clin. Cancer Res. 11: 3250-3256.
20. MARTEY, C.A. et al. 2004. Cigarette smoke induces cyclooxygenase-2 and microsomal prostaglandin E2 synthase in human lung fibroblasts: implications for lung inflammation and cancer. Am. J. Physiol. Lung Cell. Mol. Physiol. 287: L981-L991.
21. MARX, J. 2004. Cancer research. Inflammation and cancer: the link grows stronger. Science 306: 966-968.
22. SKAPINYECZ, J. et al. 2003. Pelvic inflammatory disease is a risk factor for cervical cancer. Eur. J. Gynaecol. Oncol. 24: 401-404.
23. SMITH, J.S. et al. 2002. Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. J. Infect. Dis. 185: 324-331.
24. HAWES, S.E. & N.B. KIVIAT. 2002. Are genital infections and inflammation cofactors in the pathogenesis of invasive cervical cancer? J. Natl. Cancer Inst. 94: 1592-1593.
25. FERRANDINA, G. et al. 2004. Prognostic role of the ratio between cyclooxygenase-2 in tumor and stroma compartments in cervical cancer. Clin. Cancer Res. 10: 3117-3123.
26. KIM, M.H. et al. 2003. Expression of cyclooxygenase-1 and -2 associated with expression of VEGF in primary cervical cancer and at metastatic lymph nodes. Gynecol. Oncol. 90: 83-90.
27. RYU, H.S. et al. 2000. High cyclooxygenase-2 expression in stage IB cervical cancer with lymph node metastasis or parametrial invasion. Gynecol. Oncol. 76: 320-325.
28. CHEN, H.H. et al. 2005. Increased expression of nitric oxide synthase and cyclooxygenase-2 is associated with poor survival in cervical cancer treated with radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 63: 1093-1100.
29. PRIO, T.K. et al. 2002. Asymptomatic bacteriuria in elderly humans is associated with increased levels of circulating TNF receptors and elevated numbers of neutrophils. Exp. Gerontol. 37: 693-699.
30. PFEILSCHIFTER, J. et al. 2002. Changes in proinflammatory cytokine activity after menopause. Endocr. Rev. 23: 90-119.
31. GRIMBLE, R.F. 2003. Inflammatory response in the elderly. Curr. Opin. Clin. Nutr. Metab. Care 6: 21-29.
32. MASFERRER, J.L. et al. 2000. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res. 60: 1306-1311.
33. YOSHIMURA, R. et al. 2000. Expression of cyclooxygenase-2 in prostate carcinoma. Cancer 89: 589-596.
34. JOHNSON, G.A. et al. 1997. Epidermal growth factor receptor in vulvar malignancies and its relationship to metastasis and patient survival. Gynecol. Oncol. 65: 425-429.